A method for the non-covalent immobilization of heparin to surfaces

Analytical Biochemistry

Volumn 330, Issue 1, 2004, Pages 123-129

  Mahoney, David J ^a   Whittle, Jason D ^b   Milner, Caroline M ^a   Clark, Simon J ^a   Mulloy, Barbara ^c   Buttle, David J ^d   Jones, Gavin C ^d   Day, Anthony J ^a   Short, Robert D ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Plasso Technology Ltd   (United Kingdom)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; HYDRAULIC STRUCTURES; PLASMA POLYMERIZATION; PLATES (STRUCTURAL COMPONENTS); PROTEINS; SULFUR COMPOUNDS; TISSUE HOMEOSTASIS;

BIOLOGICAL PROCESS; CELLULAR PROLIFERATIONS; GLYCOSAMINOGLYCANS; HEPARIN-BINDING PROTEINS; HIGH MOLECULAR WEIGHT; NON-COVALENT IMMOBILIZATION; PROTEIN INTERACTION; VIRAL PATHOGENESIS;

POLYSACCHARIDES;

COMPLEMENT FACTOR H; HEPARIN; HEPARIN BINDING PROTEIN; INTERLEUKIN 8; RECOMBINANT MURINE KC; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR STIMULATED GENE 6; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; IMMOBILIZATION; MICROTITER PLATE ASSAY; MOLECULAR WEIGHT; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION; TECHNIQUE;

EID: 2942581171     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.03.055     Document Type: Article

References (44)

1. Mulloy B., Linhardt R.J. Order out of complexity - protein structures that interact with heparin. Curr. Opin. Struct. Biol. 11:2001;623-628
2. Turnbull J., Powell A., Guimond S. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 11:2001;75-82
3. Shukla D., Liu J., Blaiklock P., Shworak N.W., Bai X., Esko J.D., Cohen G.H., Eisenberg R.J., Rosenberg R.D., Spear P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 99:1999;13-22
4. Pellegrini L. Role of heparan sulfate in fibroblast growth factor signalling: a structural view. Curr. Opin. Struct. Biol. 11:2001;629-634
5. Schlessinger J., Plotnikov A.N., Ibrahimi O.A., Eliseenkova A.V., Yeh B.K., Yayon A., Linhardt R.J., Mohammadi M. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell. 6:2000;743-750
6. Capila I., Linhardt R.J. Heparin-protein interactions. Angew. Chem. Int. Ed. Engl. 41:2002;391-412
7. Iwasaki W., Nagata K., Hatanaka H., Inui T., Kimura T., Muramatsu T., Yoshida K., Tasumi M., Inagaki F. Solution structure of midkine, a new heparin-binding growth factor. EMBO J. 16:1997;6936-6946
8. Mikhailov D., Young H.C., Linhardt R.J., Mayo K.H. Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha. Induction of a partially folded state and implications for heparin-induced thrombocytopenia. J. Biol. Chem. 274:1999;25317-25329
9. G.C. Jones, M.N. Vankemmelbeke, L.W. Wang, S.S. Apte, B. Mulloy, A.J. Day, D.J. Buttle, ADAMTS-4 and -5 bind to highly sulphated glycosaminoglycans. Effects of aggrecan and versican glycosaminoglycan side-chains on enzyme activity (submitted)
10. Lonky S.A., Marsh J., Wohl H. Stimulation of human granulocyte elastase by platelet factor 4 and heparin. Biochem. Biophys. Res. Commun. 85:1978;1113-1118
11. Yu W.-H., Yu S.C., Meng Q., Brew K., Woessner J.F. TIMP-3 binds to sulphated glycosaminoglycans of the extracellular matrix. J. Biol. Chem. 275:2000;31226-31232
12. Kuschert G.S., Hoogewerf A.J., Proudfoot A.E., Chung C.W., Cooke R.M., Hubbard R.E., Wells T.N., Sanderson P.N. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry. 37:1998;11193-11201
13. Hasan M., Najjam S., Gordon M.Y., Gibbs R.V., Rider C.C. IL-12 is a heparin-binding cytokine. J. Immunol. 162:1999;1064-1070
14. Mummery R.S., Rider C.C. Characterisation of the heparin binding properties of IL-6. J. Immunol. 165:2000;5671-5679
15. Sadir R., Baleux F., Grosdidier A., Imberty A., Lortat-Jacob H. Characterization of the stromal cell-derived factor-1α-heparin complex. J. Biol. Chem. 276:2001;8288-8296
16. Middleton J., Neil S., Wintle J., Clark-Lewis I., Moore H., Lam C., Auer M., Hub E., Rot A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell. 91:1997;385-395
17. Hub E., Rot A. Binding of RANTES, MCP-1, MCP-3 and MIP-1α to cells in human skin. Am. J. Pathol. 152:1998;749-757
18. Hoogewerf A.J., Kuschert G.S.V., Proudfoot A.E.I., Borlat F., Clark-Lewis I., Power C.A., Wells T.N.C. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry. 36:1997;13570-13578
19. Amara A., Lorthoir O., Valuenzuela A., Magerus A., Thelen M., Montes M., Virelizier J.-L., Delepierre M., Baleux F., Lortat-Jacob H., Arenzana-Seisdedos F. Stromal cell-derived factor-1α associates with heparan sulfates through the first β-strand of the chemokine. J. Biol. Chem. 274:1999;23916-23925
20. Zhang F., Fath M., Marks R., Linhardt R.J. A highly stable conjugated heparin biochip for heparin-protein interaction studies. Anal. Biochem. 304:2002;271-273
21. Sachchidanand, Lequin O., Staunton D., Mulloy B., Forster M.J., Yoshida K., Campbell I.D. Mapping the heparin-binding site on the 13-14F3 repeat of fibronectin. J. Biol. Chem. 277:2002;50629-50635
22. Hernaiz M.J., LeBrun L.A., Wu Y., Sen J.W., Linhardt R.J., Heegaard N.H.H. Characterization of heparin binding by a peptide from amyloid P component using capillary electrophoresis, surface plasmon resonance and isothermal titration calorimetry. Eur. J. Biochem. 269:2002;2860-2867
23. Rathore D., McCutchan T.F., Garboczi D.N., Toida T., Hernaiz M.J., LeBrun L.A., Lang S.C., Linhardt R.J. Direct measurement of the interactions of glycosaminoglycans and a heparin decasaccharide with malaria circumsporozoite protein. Biochemistry. 40:2001;11518-11524
24. Mulloy B., Forster M.J. Conformation and dynamics of heparin and heparan sulfate. Glycobiology. 10:2000;1147-1156
25. Drummond K.J., Yates E.A., Turnbull J.E. Electrophoretic sequencing of heparin/heparan sulfate oligosaccharides using a highly sensitive fluorescent end label. Electrophoresis. 22:2001;304-310
26. Wu Z.L., Zhang L., Beeler D.L., Kuberan B., Rosenberg R.D. A new strategy for defining functional groups on heparan sulfate. FASEB J. 16:2002;539-545
27. Najjam S., Gibbs R.V., Gordon M.Y., Rider C.C. Characterization of human recombinant interleukin 2 binding to heparin and heparan sulfate using an ELISA approach. Cytokine. 9:1997;1013-1022
28. Day A.J., Aplin R.T., Willis A.C. Overexpression, purification and refolding of Link module from human TSG-6 in Escherichia coli: effect of temperature, media and mutagenesis on lysine misincorporation at arginine AGA codons. Protein Express. Purif. 8:1996;1-16
29. Kahmann J.D., O' Brien R., Werner J.M., Heinegard D., Ladbury J.E., Campbell I.D., Day A.J. Localisation and characterization of the hyaluronan-binding site on the Link module from human TSG-6. Structure. 8:2000;763-774
30. Parkar A.A., Day A.J. Overlapping sites on the Link module of human TSG-6 mediate binding to hyaluronan and chondroitin-4-sulphate. FEBS Lett. 410:1997;413-417
31. Gray E., Walker A.D., Mulloy B., Barrowcliffe T.W. A collaborative study to establish the 5th international standard for unfractionated heparin. Thromb. Haemost. 84:2000;1017-1022
32. Mulloy B., Gray E., Barrowcliffe T.W. Characterisation of unfractionated heparin: comparison of materials from the last 50 years. Thromb. Haemost. 84:2000;1052-1056
33. Sim R.B., Day A.J., Moffatt B.E., Fontaine M. Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol. B. 223:1993;13-35
34. Hsiung L.-M., Barclay A.N., Brandon M.R., Sim E., Porter R.R. Purification of human C3B inactivator by monoclonal antibody affinity chromatography. Biochem. J. 203:1982;293-298
35. Lesley J., English N.M., Gal I., Mikecz K., Day A.J., Hyman R. Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6. J. Biol. Chem. 277:2002;26600-26608
36. Whittle J.D., Short R.D., Douglas C.W.I., Davies J. Differences in the aging of allyl alcohol, acrylic acid, allylamine, and octa-1, 7-diene plasma polymers as studied by X-ray photoelectron spectroscopy. Chem. Materials. 12:2000;2664-2671
37. Mahoney D.J., Blundell C.D., Day A.J. Mapping the hyaluronan binding site on the link module from human tumor necrosis factor-stimulated gene-6 by site-directed mutagenesis. J. Biol. Chem. 276:2001;22764-22771
38. Yasuda H.K. Plasma Polymerisation. 1985;Academic press, Orlando
39. Beamson G., Briggs D. High resolution XPS of Organic Polymers - The ESCA300 database. 1992;Wiley, New York
40. Calderon J.G., Harsch A., Gross G.W., Timmons R.B. Stability of plasma-polymerised allylamine films with sterilisation by autoclaving. J. Biomed. Materials Res. 42:1998;597-603
41. Milner C.M., Day A.J. TSG-6: a multifunctional protein associated with inflammation. J. Cell Sci. 116:2003;1863-1873
42. Kohda D., Morton C.J., Parkar A.A., Hatanaka H., Inagaki F.M., Campbell I.D., Day A.J. Solution structure of the Link module: a hyaluronan-binding domain involved in extracellular matrix stability and cell migration. Cell. 86:1996;767-775
43. Parkar A.A., Kahmann J.D., Howat S.L.T., Bayliss M.T., Day A.J. TSG-6 interacts with hyaluronan and aggrecan pH in a pH-dependent manner via a common functional element: implications for its regulation in inflamed cartilage. FEBS Lett. 428:1998;171-176
44. Perkins S.J., Goodship T.H.J. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site. J. Mol. Biol. 316:2002;217-224